Adams ranks high on Deloitte list
Adams Respiratory Therapeutics ranked No. 7 in Deloitte & Touche’s Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area, the company announced Monday.
"We are very proud to be recognized by Deloitte for achieving a revenue growth rate of 1,638 percent from 2002 to 2006," commented Michael Valentino, chief executive officer of Adams, on the distinction. "It has been exhilarating to see the things we’ve done take hold. Our unique regulatory strategy for Mucinex coupled with our synergistic blend of consumer and professional marketing for the Mucinex brand helped fuel our phenomenal growth over the past five years. … We now market nine over-the-counter products with multiple new product introductions planned this fall. Additionally, we also plan to expand into the prescription respiratory market as early as 2008."